98%
921
2 minutes
20
Olanzapine is an antipsychotic drug that has been reported to suppress ferroptosis, a recently discovered form of regulated cell death. In this work, the scavenging activity of olanzapine and some of its metabolites is investigated using state-of-the-art density functional theory calculations (level of theory: (SMD)-M06-2X/6-311+G(d,p)//M06-2X/6-31G(d)). Indeed, this reactivity is linked to the therapeutic activity of many antipsychotic drugs and ferroptosis inhibitors. Furthermore, the distinction between hydrogen atom transfer (HAT) and concerted proton coupled electron transfer (cPCET) is elucidated for the most reactive sites of the studied molecules. Then, a promising experimentally guided anti-ferroptotic cyclic mechanism is proposed for ferrostatin-1, a well-known ferroptosis inhibitor, involving the oxidation of Fe to Fe, the quenching of hydroperoxyl radicals, and the subsequent regeneration of the reactant (level of theory: M06/6-311+G(d,p),def2TZVP//M06/6-31G(d),LANL2DZ). An analogous cyclic process is investigated for liproxstatin-1 and olanzapine, whose activity has been reported in the literature and compared to ferrostatin-1. Finally, the effect of water solvation is evaluated unveiling that the anti-ferroptotic activity of olanzapine is likely less efficient in polar media.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/acs.inorgchem.4c02534 | DOI Listing |
J Appl Toxicol
August 2025
Department of Toxicology, Hoshi University School of Pharmacy and Pharmaceutical Sciences, Tokyo, Japan.
Typical prescribed opioids are known to inhibit intestinal transit and induce emesis-like behaviors in animals via distinct mechanisms and varying magnitudes. However, there is limited evidence regarding whether atypical opioids also produce these adverse effects in animals. This study was designed to investigate whether tramadol, its active metabolite O-desmethyltramadol (M1), and methadone cause such side effects and to elucidate their underlying mechanisms.
View Article and Find Full Text PDFSci Rep
August 2025
Herbal Pharmacology Research Center, TeMS.C., Islamic Azad University, Tehran, Iran.
Schizophrenia is a severe chronic neuropsychiatric disorder with a wide-range of cognitive and mental deficits and different categories of symptoms including positive, negative, and cognitive symptoms. In rodents, sub-chronic ketamine administration is a common method to induce a schizophrenia-like state. Olanzapine, an atypical antipsychotic medication, is used for the treatment and management of schizophrenia symptoms.
View Article and Find Full Text PDFBiochem Pharmacol
August 2025
Bristol Medical School, Biomedical Sciences Building, University Walk, Bristol BS8 1TD, UK. Electronic address:
Synthetic cannabinoid receptor agonists (SCRAs) are illicit 'street' drugs (colloquially known as "K2", "Spice" or "Mamba"), the use of which has been linked to QT interval prolongation and changes in T wave morphology. Machine learning models have predicted that SCRAs have some propensity to interact with hERG potassium channels. This study was conducted to evaluate effects of the SCRA 5F-AKB48 on hERG channel electrophysiology.
View Article and Find Full Text PDFPharmaceutics
June 2025
Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Pharos University in Alexandria, Alexandria 21648, Egypt.
: Olanzapine (Ola) is a second-generation antipsychotic with clinical utility limited by poor brain bioavailability due to blood-brain barrier restriction, hepatic first-pass metabolism, and systemic side effects. This study aimed to develop and optimize a novel intranasal polymersome-based nanocarrier (Poly) to enhance brain targeting, therapeutic efficacy, and safety of Ola. : Poly was prepared using poloxamer 401 and optimized through a Box-Behnken Design to minimize particle size and maximize entrapment (EE%) and loading efficiency (LE%).
View Article and Find Full Text PDFLife (Basel)
July 2025
PerMed Research Group, RISE-Health, Faculty of Medicine, University of Porto, Alameda Professor Hernâni Monteiro, 4200-319 Porto, Portugal.
Neuro-oncology focuses on the diagnosis and treatment of brain tumors, which, despite their rarity, are associated with high mortality due to their invasiveness and limited treatment options. Emerging evidence suggests that dopamine (DA), a neurotransmitter crucial for cognitive and emotional processes, and its receptors may influence tumor growth and the tumor microenvironment. This study aimed to evaluate the potential anticancer effects of repurposed antipsychotic dopamine-targeting drugs (Clozapine, CLZ; Pimozide, PIM; Olanzapine, OLZ; and Risperidone, RIS) and antiemetic drugs (Domperidone, DOM; Droperidol, DRO) on neuroblastoma (SH-SY5Y) and glioblastoma (A172) cell lines, and to assess whether their efficacy is modulated by oxidative stress and DA synthesis.
View Article and Find Full Text PDF